One study revealed that the 11β-hydroxysteroid dehydrogenase type 1–glucocorticoid receptor (11β-HSD1-GR) regulatory axis plays an important role in the process of switching to the M1/M2 phenotype and prevention of this process may be a potential therapeutic target for obesity (45). The gene discussed is NR3C1; the disease is Obesity.